Through its neurovascular platform, Cerenovus, Johnson & Johnson MedTech is dedicated to advancing stroke care through innovative, evidence-based technologies designed to improve clinical outcomes and save lives. With a comprehensive portfolio for both ischemic and hemorrhagic stroke treatment, Cerenovus supports physicians across every stage of neurovascular intervention..
Designed to support rapid revascularization and effective clot removal in acute ischemic stroke.
Technologies developed to support aneurysm treatment, vascular occlusion, and prevention of rebleeding.